ランダム化比較試験の報告における環境持続可能性への配慮
Florien S van Royen1, Ewoud Schuit2
1Department of General Practice and Nursing Science, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.
The Lancet. Planetary health
|January 15, 2026
まとめ
ランダム化比較試験(RCT)はかなりの二酸化炭素排出量を発生させます。この研究では、環境持続可能性がRCTの出版物で報告されることはめったにないことがわかり、より良い認識と報告戦略の必要性を示唆しています。
科学分野:
- 環境科学
- 臨床研究
- 公衆衛生
背景:
- ランダム化比較試験(RCT)は二酸化炭素排出量に寄与します。
- RCTにおける研究デザインと介入の環境への影響は、しばしば見過ごされています。
研究 の 目的:
- RCTの一次出版物における環境持続可能性への配慮の報告を評価すること。
- RCTが資源利用、移動、環境への影響をどの程度扱っているかを特定すること。
主な方法:
- 2022年10月から2023年10月にかけて5つの主要医学雑誌に掲載された252件のRCTのレビュー。
- 研究デザインと結果における環境持続可能性に関する記述の一次出版物の分析。
主要な成果:
- 持続可能性関連の記述を含んだRCTはわずか12%(29/252)でした。
- 研究デザインまたは結果で明示的に持続可能性に言及したのはわずか1.6%(4/252)でした。
- 環境持続可能性の側面は、RCTの出版物ではほとんど報告されていません。
結論:
- RCTにおける環境持続可能性の報告には大きなギャップがあります。
- 臨床試験研究における持続可能性の認識と報告を改善するための戦略が必要です。
- 持続可能な医療実践のためには、RCTに環境への配慮を統合することが不可欠です。
関連する概念動画
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
407
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
407
Clinical Trials
10.2K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
10.2K
Clinical Trials: Overview
4.6K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.6K
Blinding
3.8K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
3.8K
Randomized Experiments
8.9K
The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
Simple randomization
Simple...
8.9K
Bioavailability Study Design: Healthy Subjects Versus Patients
144
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
144


